NVNO
enVVeno Medical Corp
NASDAQ · Healthcare · Medical - Devices · US
$6.91
−3.76%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +27.6%
- EBIT
- +30.4%
- EPS
- +81.7%
- Free cash flow
- +22.2%
- Operating cash flow
- +22.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- +69.8%
- EPS
- +97.0%
Three-year CAGR
- Revenue
- —
- EBITDA
- +10.8%
- EBIT
- +12.3%
- Net income
- +10.8%
- EPS
- +97.9%
- Free cash flow
- +7.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026